Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain SRPT message board posts where the ticker symbol SRPT has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest SRPT SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-063987 Size: 5 KB
2017-12-05
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001209191-17-063973 Size: 3 KB
2017-12-05
8-K  Documents Current report, item 5.02
Acc-no: 0001193125-17-360889 (34 Act)  Size: 15 KB
2017-12-05 001-14895
171238717
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-063683 Size: 9 KB
2017-12-04
8-K  Documents Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
Acc-no: 0001193125-17-342583 (34 Act)  Size: 1 MB
2017-11-14 001-14895
171201837
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-17-026060 Size: 4 KB
2017-11-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-059861 Size: 8 KB
2017-11-08
S-8  Documents Securities to be offered to employees in employee benefit plans
Acc-no: 0001193125-17-329546 (33 Act)  Size: 56 KB
2017-11-01 333-221271
171169525
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001564590-17-020808 (34 Act)  Size: 9 MB
2017-11-01 001-14895
171169394
8-K  Documents Current report, items 8.01 and 9.01
Acc-no: 0001193125-17-319273 (34 Act)  Size: 106 KB
2017-10-25 001-14895
171153187
More SRPT SEC Filings


Related news from
Fri, 08 Dec 2017
13:04:17 +0000
See what the IHS Markit Score report has to say about Sarepta Therapeutics Inc.
Sarepta Therapeutics Inc NASDAQ/NGS:SRPT
Thu, 07 Dec 2017
13:15:00 +0000
Here's What Caused Sarepta Therapeutics to Shoot 13% Higher In November
The company's well on its way to transforming muscular dystrophy treatment.
Wed, 06 Dec 2017
14:07:02 +0000
The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics
The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics
Tue, 05 Dec 2017
14:46:02 +0000
Here's Why Sarepta Stock is Up More Than 70% in 6 Months
Sarepta's (SRPT) key product, Exondys 51, and lead pipeline candidate, golodirsen, have put up a good show in the past six months.
Tue, 05 Dec 2017
13:30:00 +0000
Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors
CAMBRIDGE, Mass., Dec. 05, 2017-- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular ...
Tue, 05 Dec 2017
13:09:01 +0000
5 Top-Ranked Drug Stocks that are Broker Favorites
With the pharma and biotech sector bouncing back in 2017, here is a look at five drug stocks including Sarepta (SRPT) that are broker favorites.
Fri, 01 Dec 2017
22:28:10 +0000
4 Biotech Stocks to Better Your Financial Health This Winter
The biotech industry shows a solid performance so far this year except for a brief slump in between of late. However, it is a good idea to select stocks from a sector that is fundamentally strong.
Thu, 30 Nov 2017
23:30:00 +0000
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Nov. 30, 2017-- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular ...
Thu, 30 Nov 2017
13:00:00 +0000
Report: Exploring Fundamental Drivers Behind Morgan Stanley, TripAdvisor, Xerox, Sarepta Therapeutics, Semgroup, and Toll Brothers — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Nov. 30, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Morgan ...
Tue, 21 Nov 2017
13:30:04 +0000
Six promising stocks to buy for the biotech rebound ahead
A big selloff last week clears the way for buying opportunities, says Michael Brush.
Wed, 15 Nov 2017
21:02:00 +0000
Sarepta Therapeutics Is on Track for Further Gains
Look for an increase to the low $60s followed by the $75 area longer term.
Wed, 15 Nov 2017
13:42:01 +0000
Is the Options Market Predicting a Spike in Sarepta Therapeutics (SRPT) Stock?
Surging implied volatility makes Sarepta Therapeutics (SRPT) Stock lucrative to the option traders.
Tue, 14 Nov 2017
13:10:00 +0000
Today’s Research Reports on Trending Tickers: Novavax and Sarepta Therapeutics
NEW YORK, NY / ACCESSWIRE / November 14, 2017 / After posting its first weekly loss in two months on Friday, the Dow Jones and S&P 500 Index opened the week in the green on Monday. The Dow Jones Industrial ...
Fri, 10 Nov 2017
13:25:00 +0000
[$$] Sarepta: Too Much Good News to Ignore
Sarepta Therapeutics (SRPT) has moved to solidify its position as the leading company in the treatment of Duchenne muscular dystrophy (DMD) with the recent announcement of three new clinical trials. Sarepta CEO Doug Ingram called the Anthem move “a fantastic result for children with DMD” in a Barron’s interview Thursday. The selloff probably reflects hedging activity by convertible arbitragers who purchased the big Sarepta convertible.
Fri, 10 Nov 2017
02:45:00 +0000
Sarepta Therapeutics Announces Exercise of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes Due 2024
CAMBRIDGE, Mass., Nov. 09, 2017-- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is one of the brightest and most generous groups you will ever come across. While I firmly believe everyone has something to contribute to the collective wisdom, this is pretty much a left-brain group. Facts, evidence, and reasoned argument will earn you respect, even if some disagree with you." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards